ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SPARC_BE announcements Sun Pharma Adv.res.co.ltd announcements and dividends declared NSE

Sun Pharma Adv.res.co.ltd Complete list of announcements declared & dividend announcements by Sun Pharma Adv.res.co.ltd SPARC_BE

Sun Pharma Adv.res.co.ltd SPARC_BE listed on NSE and deals in

Announcements and dividends declared by Sun Pharma Adv.res.co.ltd SPARC_BE

New launches and R&D pipeline bolster Sun Pharma's long-term growth outlook
Sun Pharma reported robust global specialty growth and resilient domestic sales in Q3, despite US generics headwinds. Recent product launches and pipeline advancements, including Unloxcyt and Leqselvi, are poised to drive long-term growth. Analysts maintai
Announcement as on 10 November 2025

Sun Pharma’s US innovative drug sales surpass generics for the first time
Sun Pharma's U.S. innovative medicine sales have surpassed generics for the first time, driven by key products like Ilumya and Cequa. The launch of Leqselvi for alopecia has been well-received, with further growth anticipated from upcoming launches like Un
Announcement as on 06 November 2025

Sun Pharma's US innovative drug sales surpass generics for first time
Sun Pharma is open to expanding its US manufacturing capabilities in response to the Trump administration's 100% tariff on medicines. The company is evaluating its current footprint and considering localization options, though the tariff's impact on its pr
Announcement as on 05 November 2025

Sun Pharma Q2 Preview: PAT may rise 2% YoY; Leqselvi spending to weigh on margins
Sun Pharma is expected to report modest Q2 FY26 earnings growth, with PAT likely up 2% YoY and revenue rising 7%. Analysts cite Leqselvi launch costs, weak Taro performance, and high R&D spend as margin drags, even as domestic and specialty segments co
Announcement as on 04 November 2025

Sun Pharma Share Price Highlights: Sun Pharma Stock Price History

Announcement as on 31 October 2025

Announcements by Sun Pharma Adv.res.co.ltd first page | Next page | Prev page |

SPARC_BE Sun Pharma Adv.res.co.ltd current price & indicator signals

Moving Averages for Sun Pharma Adv.res.co.ltd

  • 5Day Average: 350.97
  • 12Day Average: 395.03
  • 20Day Average: 385.41
  • 50Day Average: 372.54

SPARC_BE Indicators & signals

Indicator MACD (12,26,9)

373.39, 378.61, 6.06
Indicator MACD is in negative zone

Indicator ADX (14)

36.69, 21.24, 45.86
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SPARC_BE Sun Pharma Adv.res.co.ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Mon Apr 2024 315.95 315.95 to 315.95 -4.99% 0.34 times
19 Fri Apr 2024 332.55 332.55 to 332.55 -5% 0.23 times
18 Thu Apr 2024 350.05 350.05 to 350.05 -4.99% 0.3 times
16 Tue Apr 2024 368.45 368.45 to 368.45 -5% 0.23 times
15 Mon Apr 2024 387.85 387.85 to 387.85 -5% 0.16 times
12 Fri Apr 2024 408.25 408.25 to 408.25 -4.99% 0.2 times
10 Wed Apr 2024 429.70 429.70 to 429.70 -5% 0.24 times
09 Tue Apr 2024 452.30 437.30 to 472.80 -0.66% 1.95 times
08 Mon Apr 2024 455.30 455.30 to 455.30 4.99% 1.7 times
05 Fri Apr 2024 433.65 410.00 to 433.65 5% 2.82 times
04 Thu Apr 2024 413.00 396.00 to 413.00 5% 2.17 times
03 Wed Apr 2024 393.35 375.00 to 395.00 2.37% 1.06 times

Videos related to: SPARC_BE announcements Sun Pharma Adv.res.co.ltd announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SPARC_BE announcements Sun Pharma Adv.res.co.ltd announcements and dividends declared NSE

 

Back to top